超越前列腺:关于良性前列腺增生药物对眼睛的影响的有远见的研究
Hamza Khan1, Owais M Aftab1, Mubashir Shabil Billah2
1Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
概括
良性前列腺增生症 (BPH) 药物,特别是坦苏洛辛和费纳斯特,与严重的眼部副作用有关. 对FDA数据的分析揭示了虹膜,角膜和视网膜问题的安全信号,需要进一步调查.
科学领域:
- 眼科医生 眼科 眼科
- 药物监督 药物监督 药物监督
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 众所周知,良性前列腺增生症 (BPH) 药物会引起特定的虹膜不良反应.
- 对于药物安全来说,对病理学上的不良眼睛影响进行全面的分析至关重要.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 是药物监测的宝贵资源.
研究的目的:
- 使用FAERS数据对与BPH药物相关的眼部不良事件进行全面分析.
- 确定与BPH治疗相关的眼部不良影响的显著药物安全信号.
- 研究特定BPH药物与各种眼部病理之间的相关性.
主要方法:
- 在FAERS数据 (2004-2023Q3) 上使用不成比例分析 (PRR,ROR,EGM,IC).
- 审查了11,439,756份独特的不良事件报告,重点关注与BPH药物相关的1,682份.
- 通过将眼部不良事件与tamsulosin和finasteride等BPH药物进行比较,确定了安全信号.
主要成果:
- 坦苏洛辛 (80.67%) 和费纳斯特 (10.71%) 是报告最多的BPH药物.
- 主要的眼部不良事件类别包括虹膜/白内障症状 (51.78%) 和视觉/神经变化 (29.90%).
- 对虹膜,黄斑纤维化,角膜变化,眼腺问题,视网膜退化/脱离,玻璃体浮动物和视网膜,观察到重要的安全信号.
结论:
- FAERS不成比例性分析发现了BPH药物的显著药物安全信号.
- 需要进一步探索BPH药物与严重的眼部不良影响之间的联系.
- 具体问题包括黄斑纤维化,角膜病理,眼腺变化和黄斑.
相关概念视频
Open Angle Glaucoma: Treatment
570
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
570
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
251
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
251
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
972
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
972
Angle Closure Glaucoma: Treatment
684
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
684
Antihypertensive Drugs: Vasodilators
643
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
643
Direct-Acting Cholinergic Agonists: Therapeutic Uses
885
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
885


